Home World KKR to Acquire Gen II in $5.1 Billion Deal
WorldBusiness

KKR to Acquire Gen II in $5.1 Billion Deal

Share
KKR to Acquire Gen II in $5.1 Billion Deal
Share

Global investment firm KKR has agreed to acquire Gen II Fund Services, a private-capital fund administrator, in a deal valued at $5.1 billion including debt.

KKR will buy Gen II from Hg, General Atlantic and other minority investors. Gen II provides tax, compliance, treasury and technology services to private equity, private credit and other private-market managers.

The company serves more than 275 investment firms representing more than $2 trillion in private-fund capital. Its co-founder and chief executive, Steven Millner, will remain in charge following the acquisition.

The transaction is expected to close in 2027, subject to customary conditions and regulatory approvals.

The acquisition gives KKR a larger presence in the financial services infrastructure supporting the expanding private-markets industry. Demand for fund administration has grown as private investment firms manage increasingly complex funds and face greater regulatory and reporting requirements.

For KKR, the deal also fits its broader expansion across financial services and businesses connected to alternative investments. The firm has increasingly invested in companies that provide services to asset managers rather than relying only on direct investments in assets.

See also  Ventures Platform raises $84m to back Africa’s next generation of startups
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Digital Payment Use Rises Among Nigerians Despite Fraud Experiences, Report Reveals

The 2026 State of Inclusive Instant Payment Systems in Africa (SIIPS) report,...

Banking Sell-Off Drags NGX Down as Investors Lose N406 Billion

Investors in Nigeria's stock market lost N406.34 billion in market value on...

African Businesses Face Shutdowns, Liquidation and Licence Revocations in Third Quarter of 2026

Several businesses across Africa faced shutdowns, insolvency proceedings and regulatory action in...

New pancreatic cancer pill raises hope as tumours disappear in early trials

A new daily pill, daraxonrasib, has shown promising results in early clinical...